• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响超低分子量壳聚糖/透明质酸纳米粒转染效率的因素。

Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles.

作者信息

Duceppe Nicolas, Tabrizian Maryam

机构信息

Department of Biomedical Engineering, Duff Medical Sciences Building, 3775 University Street, McGill University, Montreal H3A 2B4, Canada.

出版信息

Biomaterials. 2009 May;30(13):2625-31. doi: 10.1016/j.biomaterials.2009.01.017. Epub 2009 Feb 6.

DOI:10.1016/j.biomaterials.2009.01.017
PMID:19201022
Abstract

The present work describes nanoparticles made of ultra low molecular weight chitosan (ULMWCh)/hyaluronic acid (HA) as novel potential carriers for gene delivery. Small and monodispersed nanoparticles with high in vitro transfection capabilities have been obtained by the complexation of these two polyelectrolytes. ULMWCh (<10 kDa) presents more advantageous characteristics over the higher molecular weight chitosan for clinical applications, namely increased solubility at physiological pH and improved DNA release. The ULMWCh:HA ratio and the HA molecular weights were varied with the aim of obtaining particles in the 100 nm range. Using chitosan (Ch) with a molecular weight of 5 kDa, HA with a molecular weight of 64 kDa, and a weight ratio of 4:1, nanoparticles with a Z-average size of 146+/-1 nm and narrow size distribution (polydispersity index: 0.073+/-0.030) were obtained. Nanoparticle images taken in dry conditions by SEM and AFM showed spherical particles. The optimal pH for transfection ranged from 6.4 to 6.8 for 0.25 microg of EGFP plasmid per well, with an incubation time of 4 h. Using these optimized parameters, DNA/ULMWCh:HA nanoparticles successfully transfected 25+/-1% of the 293T cells with pEGFP, compared to 0.7% obtained for DNA/ULMWCh under the same conditions. This high transfection efficiency of our non-viral gene delivery system could be attributed to the synergic effect of ULMWCh and low charge density of the HA chain for easy release of DNA which makes the system suitable for targeted gene delivery.

摘要

本研究描述了由超低分子量壳聚糖(ULMWCh)/透明质酸(HA)制成的纳米颗粒,作为新型潜在的基因传递载体。通过这两种聚电解质的络合,获得了具有高体外转染能力的小尺寸且单分散的纳米颗粒。与较高分子量的壳聚糖相比,超低分子量壳聚糖(<10 kDa)在临床应用中具有更有利的特性,即在生理pH下溶解度增加以及DNA释放改善。改变ULMWCh:HA比例和HA分子量,旨在获得尺寸在100 nm范围内的颗粒。使用分子量为5 kDa的壳聚糖(Ch)、分子量为64 kDa的HA以及重量比为4:1,获得了Z平均尺寸为146±1 nm且尺寸分布窄(多分散指数:0.073±0.030)的纳米颗粒。通过扫描电子显微镜(SEM)和原子力显微镜(AFM)在干燥条件下拍摄的纳米颗粒图像显示为球形颗粒。对于每孔0.25 μg的增强绿色荧光蛋白(EGFP)质粒,转染的最佳pH范围为6.4至6.8,孵育时间为4小时。使用这些优化参数,DNA/ULMWCh:HA纳米颗粒成功地用pEGFP转染了293T细胞的25±1%,而在相同条件下,DNA/ULMWCh的转染率为0.7%。我们的非病毒基因传递系统的这种高转染效率可归因于ULMWCh的协同作用以及HA链的低电荷密度,便于DNA释放,这使得该系统适用于靶向基因传递。

相似文献

1
Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles.影响超低分子量壳聚糖/透明质酸纳米粒转染效率的因素。
Biomaterials. 2009 May;30(13):2625-31. doi: 10.1016/j.biomaterials.2009.01.017. Epub 2009 Feb 6.
2
Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.新型透明质酸-壳聚糖纳米粒作为靶向骨关节炎的非病毒基因传递载体。
Int J Pharm. 2011 Nov 28;420(2):358-65. doi: 10.1016/j.ijpharm.2011.08.046. Epub 2011 Sep 3.
3
Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.透明质酸包覆壳聚糖纳米粒:分子量依赖性对形态和透明质酸呈现的影响。
J Control Release. 2013 Dec 28;172(3):1142-50. doi: 10.1016/j.jconrel.2013.09.032. Epub 2013 Oct 6.
4
Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.制备参数对超低分子量壳聚糖/透明质酸纳米粒子的影响。
Int J Biol Macromol. 2013 Nov;62:642-6. doi: 10.1016/j.ijbiomac.2013.09.041. Epub 2013 Oct 4.
5
Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.基于两亲性壳聚糖衍生物和透明质酸的自组装纳米粒用于基因递送。
Carbohydr Polym. 2013 Apr 15;94(1):309-16. doi: 10.1016/j.carbpol.2012.12.058. Epub 2013 Jan 5.
6
[Synthesis and characterization of chitosan-DNA nanoparticles as gene carriers].壳聚糖-DNA纳米颗粒作为基因载体的合成与表征
Nan Fang Yi Ke Da Xue Xue Bao. 2007 May;27(5):595-8.
7
Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles.使用壳聚糖-聚乙二醇化绿色荧光蛋白纳米颗粒转染原代软骨细胞。
J Control Release. 2006 May 15;112(2):223-8. doi: 10.1016/j.jconrel.2006.01.016. Epub 2006 Mar 23.
8
Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.基于壳聚糖-脱氧胆酸钠纳米粒的新型质粒递释系统的构建与特性研究。
Eur J Pharm Sci. 2012 Mar 12;45(4):451-8. doi: 10.1016/j.ejps.2011.09.018. Epub 2011 Oct 1.
9
Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells.壳聚糖-质粒DNA纳米颗粒的特性决定了基因传递至人间充质干细胞的转染效率。
Artif Cells Nanomed Biotechnol. 2014 Dec;42(6):376-84. doi: 10.3109/21691401.2013.832685. Epub 2013 Sep 3.
10
Studies on the condensation of depolymerized chitosans with DNA for preparing chitosan-DNA nanoparticles for gene delivery applications.关于将解聚壳聚糖与DNA缩合以制备用于基因递送应用的壳聚糖-DNA纳米颗粒的研究。
J Biomed Mater Res B Appl Biomater. 2009 May;89(2):282-292. doi: 10.1002/jbm.b.31214.

引用本文的文献

1
Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles.通过负载 microRNAs 的壳聚糖纳米粒子劫持三阴性乳腺癌的 5-氟尿嘧啶化疗耐药性。
Int J Mol Sci. 2024 Feb 8;25(4):2070. doi: 10.3390/ijms25042070.
2
Polyelectrolyte Nanoparticles of Amphiphilic Chitosan/Pectin from Banana Peel as Potential Carrier System of Hydrophobic Molecules.香蕉皮两亲性壳聚糖/果胶聚电解质纳米颗粒作为疏水分子的潜在载体系统
Polymers (Basel). 2020 Sep 16;12(9):2109. doi: 10.3390/polym12092109.
3
Efficient inhibition of uveal melanoma via ternary siRNA complexes.
通过三元 siRNA 复合物高效抑制葡萄膜黑色素瘤。
Int J Pharm. 2020 Jan 5;573:118894. doi: 10.1016/j.ijpharm.2019.118894. Epub 2019 Nov 23.
4
The Microfluidic Technique and the Manufacturing of Polysaccharide Nanoparticles.微流控技术与多糖纳米颗粒的制造
Pharmaceutics. 2018 Dec 9;10(4):267. doi: 10.3390/pharmaceutics10040267.
5
Chitosan-Polylactide/Hyaluronic Acid Complex Microspheres as Carriers for Controlled Release of Bioactive Transforming Growth Factor-β1.壳聚糖-聚丙交酯/透明质酸复合微球作为生物活性转化生长因子-β1控释载体
Pharmaceutics. 2018 Nov 17;10(4):239. doi: 10.3390/pharmaceutics10040239.
6
Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.壳聚糖/透明质酸/质粒 DNA 纳米粒编码白细胞介素 1 受体拮抗剂可减轻白细胞介素 1β诱导的滑膜细胞炎症。
J Mater Sci Mater Med. 2018 Oct 1;29(10):155. doi: 10.1007/s10856-018-6160-3.
7
Biocompatibility of Gd-Loaded Chitosan-Hyaluronic Acid Nanogels as Contrast Agents for Magnetic Resonance Cancer Imaging.负载钆的壳聚糖-透明质酸纳米凝胶作为磁共振癌症成像造影剂的生物相容性
Nanomaterials (Basel). 2018 Mar 28;8(4):201. doi: 10.3390/nano8040201.
8
Anionic Polymer and Quantum Dot Excipients to Facilitate siRNA Release and Self-Reporting of Disassembly in Stimuli-Responsive Nanocarrier Formulations.用于促进小干扰RNA释放及在刺激响应性纳米载体配方中自我报告拆解的阴离子聚合物和量子点辅料
Biomacromolecules. 2017 Jun 12;18(6):1814-1824. doi: 10.1021/acs.biomac.7b00265. Epub 2017 May 10.
9
Hyaluronic Acid-Chitosan Nanoparticles to Deliver Gd-DTPA for MR Cancer Imaging.用于磁共振癌症成像的载钆喷酸葡胺的透明质酸-壳聚糖纳米颗粒
Nanomaterials (Basel). 2015 Aug 20;5(3):1379-1396. doi: 10.3390/nano5031379.
10
Improving the osteogenesis of human bone marrow mesenchymal stem cell sheets by microRNA-21-loaded chitosan/hyaluronic acid nanoparticles via reverse transfection.通过反向转染负载微小RNA-21的壳聚糖/透明质酸纳米颗粒改善人骨髓间充质干细胞片的成骨作用。
Int J Nanomedicine. 2016 May 17;11:2091-105. doi: 10.2147/IJN.S104851. eCollection 2016.